IMMY

Our Mission: Saving Lives One Diagnostic at a Time

Our Vision: To drastically reduce mortality caused by infectious diseases through increased use of affordable diagnostics.

IMMY is a US-based organization that was founded in 1979 with a particular focus in mycology, or the study of fungi. IMMY manufactures, markets, and distributes innovative lines of diagnostic tests and reagents for infectious diseases. Over the last forty years, IMMY has evolved from a company that filled a need in the market to an organization with a global focus on saving lives through the production of affordable diagnostics.

Rapid Growth Potential Recognized as one of the most successful biotech companies in the state of Oklahoma, IMMY has experienced a tremendous amount of success in recent years. This year, sales have increased over 20% compared to last year, and annual sales will have doubled since 2009. We were also named to the 2014 Metro 50, which recognizes the top 50 fastest growing companies in the Oklahoma City Metro.

Innovation is in Our DNA IMMY has released three innovative products in the last four years, and each one is positively impacting the clinical outcomes of patients all over the world. IMMY was awarded the 2014 Innovator of the Year by the Oklahoma Bioscience Association and i2E Inc. for the CrAg® LFA, a diagnostic test that will save the lives of thousands of HIV patients each year.

Building Something Great IMMY recently built a new company headquarters in Norman, OK, and quadrupled its space. IMMY is growing rapidly and is establishing systems to increase effectiveness and sustainability on a much larger scale. This is an opportunity to help shape a company at the infancy of its rise in the diagnostic industry.

IMMY takes pride in producing reliable, accurate diagnostics, but above all we want to play a role in raising the standard of healthcare for patients all over the world.